Announcements Trials
Browse Landscape

Phase

Phase 2 55Phase 3 44Phase 1/2 6Phase 1 5Phase 2/3 4Phase NA 3Phase 4 3Phase EARLY_PHASE1 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 3

Conditions

Multiple Myeloma 3Waldenstrom Macroglobulinemia 1Stomach Neoplasms 1Recurrence 1Neoplasms, Second Primary 1Neoplasms 1NSCLC 1Lymphoma, Mantle-Cell 1Immunoglobulin Light-chain Amyloidosis 1

Interventions

Dexamethasone 11Lenalidomide 10Bortezomib 9Zoledronic Acid 8ixazomib 4daratumumab 4Melphalan 4tocilizumab 3Thalidomide 3Cyclophosphamide 3pomalidomide 2carfilzomib 2Prednisone 2Kyphoplasty 2Filgrastim 2Doxorubicin 2Calcium Dobesilate 2zanubrutinib 1talquetamab 1pegylated granulocyte colony-stimulating factor 1montelukast 1isatuximab 1ibrutinib 1exifone 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1apixaban 1Vaccination 1Thiotepa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Multiple Myeloma × Thalidomide × Clear all
NCT02559154 2018-05-04

Modified Bortezomib-based Combination Therapy for Multiple Myeloma

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 4 Unknown
80 enrolled
Plasma cell

Multiple Myeloma

NCT00652041 2011-09-19

TaCyDexVMP7

PETHEMA Foundation

Phase 4 Completed
40 enrolled
Plasma cell

Multiple Myeloma, Recurrence

NCT01249690 2010-11-30

Efficacy Study of PAD and TAD in Newly Diagnosed Multiple Myeloma

Second Military Medical University

Phase 4 Unknown
100 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡